330 related articles for article (PubMed ID: 32328763)
1. High spatiotemporal resolution dynamic contrast-enhanced MRI improves the image-based discrimination of histopathology risk groups of peripheral zone prostate cancer: a supervised machine learning approach.
Winkel DJ; Breit HC; Block TK; Boll DT; Heye TJ
Eur Radiol; 2020 Sep; 30(9):4828-4837. PubMed ID: 32328763
[TBL] [Abstract][Full Text] [Related]
2. Compressed Sensing Radial Sampling MRI of Prostate Perfusion: Utility for Detection of Prostate Cancer.
Winkel DJ; Heye TJ; Benz MR; Glessgen CG; Wetterauer C; Bubendorf L; Block TK; Boll DT
Radiology; 2019 Mar; 290(3):702-708. PubMed ID: 30599102
[TBL] [Abstract][Full Text] [Related]
3. A direct comparison of contrast-enhanced ultrasound and dynamic contrast-enhanced magnetic resonance imaging for prostate cancer detection and prediction of aggressiveness.
Baur ADJ; Schwabe J; Rogasch J; Maxeiner A; Penzkofer T; Stephan C; Rudl M; Hamm B; Jung EM; Fischer T
Eur Radiol; 2018 May; 28(5):1949-1960. PubMed ID: 29238867
[TBL] [Abstract][Full Text] [Related]
4. Multiparametric MRI for Suspected Recurrent Prostate Cancer after HIFU:Is DCE still needed?
Lotte R; Lafourcade A; Mozer P; Conort P; Barret E; Comperat E; Ezziane M; de Guibert PJ; Tavolaro S; Belin L; Boudghene F; Lucidarme O; Renard-Penna R
Eur Radiol; 2018 Sep; 28(9):3760-3769. PubMed ID: 29633004
[TBL] [Abstract][Full Text] [Related]
5. MR-sequences for prostate cancer diagnostics: validation based on the PI-RADS scoring system and targeted MR-guided in-bore biopsy.
Schimmöller L; Quentin M; Arsov C; Hiester A; Buchbender C; Rabenalt R; Albers P; Antoch G; Blondin D
Eur Radiol; 2014 Oct; 24(10):2582-9. PubMed ID: 24972954
[TBL] [Abstract][Full Text] [Related]
6. Revisiting DCE-MRI: Classification of Prostate Tissue Using Descriptive Signal Enhancement Features Derived From DCE-MRI Acquisition With High Spatiotemporal Resolution.
Breit HC; Block TK; Winkel DJ; Gehweiler JE; Glessgen CG; Seifert H; Wetterauer C; Boll DT; Heye TJ
Invest Radiol; 2021 Sep; 56(9):553-562. PubMed ID: 33660631
[TBL] [Abstract][Full Text] [Related]
7. DCE-MRI of the prostate using shutter-speed vs. Tofts model for tumor characterization and assessment of aggressiveness.
Hectors SJ; Besa C; Wagner M; Jajamovich GH; Haines GK; Lewis S; Tewari A; Rastinehad A; Huang W; Taouli B
J Magn Reson Imaging; 2017 Sep; 46(3):837-849. PubMed ID: 28092414
[TBL] [Abstract][Full Text] [Related]
8. Detection of prostate cancer in peripheral zone: comparison of MR diffusion tensor imaging, quantitative dynamic contrast-enhanced MRI, and the two techniques combined at 3.0 T.
Li C; Chen M; Li S; Zhao X; Zhang C; Luo X; Zhou C
Acta Radiol; 2014 Mar; 55(2):239-47. PubMed ID: 23892233
[TBL] [Abstract][Full Text] [Related]
9. Multiparametric MRI in detection and staging of prostate cancer.
Boesen L
Dan Med J; 2017 Feb; 64(2):. PubMed ID: 28157066
[TBL] [Abstract][Full Text] [Related]
10. Quantitative diffusion-weighted imaging and dynamic contrast-enhanced characterization of the index lesion with multiparametric MRI in prostate cancer patients.
Yuan Q; Costa DN; Sénégas J; Xi Y; Wiethoff AJ; Rofsky NM; Roehrborn C; Lenkinski RE; Pedrosa I
J Magn Reson Imaging; 2017 Mar; 45(3):908-916. PubMed ID: 27442039
[TBL] [Abstract][Full Text] [Related]
11. Added value of diffusion-weighted images and dynamic contrast enhancement in multiparametric magnetic resonance imaging for the detection of clinically significant prostate cancer in the PICTURE trial.
Eldred-Evans D; Neves JB; Simmons LAM; Kanthabalan A; McCartan N; Shah TT; Arya M; Charman SC; Freeman A; Moore CM; Punwani S; Emberton M; Ahmed HU
BJU Int; 2020 Mar; 125(3):391-398. PubMed ID: 31733173
[TBL] [Abstract][Full Text] [Related]
12. Predicting clinically significant prostate cancer from quantitative image features including compressed sensing radial MRI of prostate perfusion using machine learning: comparison with PI-RADS v2 assessment scores.
Winkel DJ; Breit HC; Shi B; Boll DT; Seifert HH; Wetterauer C
Quant Imaging Med Surg; 2020 Apr; 10(4):808-823. PubMed ID: 32355645
[TBL] [Abstract][Full Text] [Related]
13. Diagnostic performance of diffusion-weighted (DWI) and dynamic contrast-enhanced (DCE) MRI for the differentiation of benign from malignant soft-tissue tumors.
Choi YJ; Lee IS; Song YS; Kim JI; Choi KU; Song JW
J Magn Reson Imaging; 2019 Sep; 50(3):798-809. PubMed ID: 30663160
[TBL] [Abstract][Full Text] [Related]
14. 4D perfusion CT of prostate cancer for image-guided radiotherapy planning: A proof of concept study.
Beer L; Polanec SH; Baltzer PAT; Schatzl G; Georg D; Schestak C; Dutschke A; Herrmann H; Mazal P; Brendel AK; Shariat SF; Ringl H; Helbich TH; Apfaltrer P
PLoS One; 2019; 14(12):e0225673. PubMed ID: 31856177
[TBL] [Abstract][Full Text] [Related]
15. Radiomic features for prostate cancer detection on MRI differ between the transition and peripheral zones: Preliminary findings from a multi-institutional study.
Ginsburg SB; Algohary A; Pahwa S; Gulani V; Ponsky L; Aronen HJ; Boström PJ; Böhm M; Haynes AM; Brenner P; Delprado W; Thompson J; Pulbrock M; Taimen P; Villani R; Stricker P; Rastinehad AR; Jambor I; Madabhushi A
J Magn Reson Imaging; 2017 Jul; 46(1):184-193. PubMed ID: 27990722
[TBL] [Abstract][Full Text] [Related]
16. Use of diffusion kurtosis imaging and quantitative dynamic contrast-enhanced MRI for the differentiation of breast tumors.
Li T; Yu T; Li L; Lu L; Zhuo Y; Lian J; Xiong Y; Kong D; Li K
J Magn Reson Imaging; 2018 Nov; 48(5):1358-1366. PubMed ID: 29717790
[TBL] [Abstract][Full Text] [Related]
17. The Utility of Diffusion-Weighted Imaging and Perfusion Magnetic Resonance Imaging Parameters for Detecting Clinically Significant Prostate Cancer.
Cindil E; Oner Y; Sendur HN; Ozdemir H; Gazel E; Tunc L; Cerit MN
Can Assoc Radiol J; 2019 Nov; 70(4):441-451. PubMed ID: 31561925
[TBL] [Abstract][Full Text] [Related]
18. Dynamic contrast-enhanced (DCE) MR imaging: the role of qualitative and quantitative parameters for evaluating prostate tumors stratified by Gleason score and PI-RADS v2.
Afshari Mirak S; Mohammadian Bajgiran A; Sung K; Asvadi NH; Markovic D; Felker ER; Lu D; Sisk A; Reiter RE; Raman SS
Abdom Radiol (NY); 2020 Jul; 45(7):2225-2234. PubMed ID: 31549211
[TBL] [Abstract][Full Text] [Related]
19. Prostate cancer local staging using biparametric MRI: assessment and comparison with multiparametric MRI.
Christophe C; Montagne S; Bourrelier S; Roupret M; Barret E; Rozet F; Comperat E; Coté JF; Lucidarme O; Cussenot O; Granger B; Renard-Penna R
Eur J Radiol; 2020 Nov; 132():109350. PubMed ID: 33080549
[TBL] [Abstract][Full Text] [Related]
20. Peripheral zone prostate cancer localization by multiparametric magnetic resonance at 3 T: unbiased cancer identification by matching to histopathology.
Selnæs KM; Heerschap A; Jensen LR; Tessem MB; Schweder GJ; Goa PE; Viset T; Angelsen A; Gribbestad IS
Invest Radiol; 2012 Nov; 47(11):624-33. PubMed ID: 23011187
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]